Tenon Medical (TNON) EBIAT (2021 - 2026)

Tenon Medical has reported EBIAT for 6 years, with the latest figure at -$3.5 million in Q1 2026.

• For the quarter ending Q1 2026, EBIAT rose 3.87% year-over-year to -$3.5 million; the trailing twelve-month figure through Mar 2026 stood at -$12.4 million (up 9.46% YoY), and the FY2025 full-year result was -$12.6 million, up 8.17% from the prior year.
• EBIAT for Q1 2026 stood at -$3.5 million, down from -$2.8 million in the prior quarter.
• The five-year high for EBIAT was -$2.4 million in Q1 2022, with the low at -$7.9 million in Q4 2022.
• Average EBIAT over 5 years is -$3.8 million, with a median of -$3.3 million recorded in 2025.
• Year-over-year, EBIAT sank 1076.5% in 2022 and soared 60.35% in 2023.
• Tracing TNON's EBIAT over 5 years: stood at -$7.9 million in 2022, then soared by 60.35% to -$3.1 million in 2023, then climbed by 1.5% to -$3.1 million in 2024, then advanced by 8.26% to -$2.8 million in 2025, then declined by 22.74% to -$3.5 million in 2026.
• The last three EBIAT figures came in at -$3.5 million (Q1 2026), -$2.8 million (Q4 2025), and -$3.3 million (Q3 2025), per Business Quant data.

Peer Comparison